Induced pluripotent stem cells in Parkinson's disease: Scientific and clinical challenges
10.1136/jnnp-2015-312036
Saved in:
Main Authors: | Xiao B., Hui Ng H., Takahashi R., Tan E.-K. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Review |
Published: |
BMJ Publishing Group
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/149006 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Patient-derived induced pluripotent stem cells and organoids for modeling alpha synuclein propagation in parkinson's disease
by: Koh, Y.H, et al.
Published: (2020) -
Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T
by: Ma D., et al.
Published: (2018) -
Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease
by: Ma D., et al.
Published: (2018) -
Future challenges for patient-specific induced pluripotent stem cells in cardiovascular medicine
by: Sun, X., et al.
Published: (2016) -
Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine
by: OH YING ZI, et al.
Published: (2016)